PCP4/PEP19 upregulates aromatase gene expression via CYP19A1 promoter I.1 in human breast cancer SK-BR-3 cells

Kie Honjo; Taiji Hamada; Takuya Yoshimura; Seiya Yokoyama; Sohsuke Yamada; Yan-Qin Tan; Lai K. Leung; Norifumi Nakamura; Yasuyo Ohi; Michiyo Higashi; Akihide Tanimoto

doi:10.18632/oncotarget.25651

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

PCP4/PEP19 upregulates aromatase gene expression via CYP19A1 promoter I.1 in human breast cancer SK-BR-3 cells

Kie Honjo, Taiji Hamada, Takuya Yoshimura, Seiya Yokoyama, Sohsuke Yamada, Yan-Qin Tan, Lai K. Leung, Norifumi Nakamura, Yasuyo Ohi, Michiyo Higashi and Akihide Tanimoto _

PDF | HTML | How to cite

Oncotarget. 2018; 9:29619-29633. https://doi.org/10.18632/oncotarget.25651

Metrics: PDF 1422 views | HTML 2345 views | ?

Abstract

Kie Honjo1,*, Taiji Hamada2,*, Takuya Yoshimura1, Seiya Yokoyama2, Sohsuke Yamada2,3, Yan-Qin Tan4, Lai K. Leung4, Norifumi Nakamura1, Yasuyo Ohi5, Michiyo Higashi2 and Akihide Tanimoto2

1Department of Oral Surgery, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan

2Department of Pathology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan

3Department of Pathology and Laboratory Medicine, Kanazawa Medical University, Ishikawa, Japan

4Faculty of Science, School of Life Sciences, Food and Nutritional Science Programme, The Chinese University of Hong Kong, Shatin, Hong Kong

5Department of Pathology, Sagara Hospital, Social Medical Corporation Hakuaikai, Kagoshima, Japan

*These authors have contributed equally to this work

Correspondence to:

Akihide Tanimoto, email: [email protected]

Keywords: PCP4/PEP19; breast cancer; aromatase; intratumoral heterogeneity

Received: December 18, 2017 Accepted: May 23, 2018 Published: July 03, 2018

ABSTRACT

The Purkinje cell protein 4/peptide 19 (PCP4/PEP19) is a novel breast cancer cell expressing peptide, originally found in the neural cells as an anti-apoptotic factor, could inhibit cell apoptosis and enhance cell migration and invasion in human breast cancer cell lines. The expression of PCP4/PEP19 is induced by estrogens in estrogen receptor-positive (ER⁺) MCF-7 cells but also highly expressed in ER^- SK-BR-3 cells. In this study, we investigated the effects of PCP4/PEP19 on aromatase gene expression in MCF-7 and SK-BR-3 human breast cancer cells. In SK-BR-3 cells but not in MCF-7 cells, PCP4/PEP19 knockdown by siRNA silencing decreased the aromatase expression in gene transcriptional level. When PCP4/PEP19 was overexpressed by CMV promoter-driven PCP4/PEP19 expressing plasmid transfection, aromatase gene transcription increased in SK-BR-3 cells. This aromatase gene transcription is mainly mediated through promoter region PI.1, which is usually active in the placental tissue but not in the breast cancer tissue. These results indicate a new function of PCP4/PEP19 that would enhance aromatase gene upregulation to supply estrogens in heterogeneous cancer microenvironment.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 25651

Publication Alerts

Research Papers:

PCP4/PEP19 upregulates aromatase gene expression via CYP19A1 promoter I.1 in human breast cancer SK-BR-3 cells

Abstract